Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2021
2021 World Conference on Lung Cancer
Presentation Date(s):- September 8 - 14, 2021
- Total Presentations: 1107
-
+
P06 - Early Stage/Localized Disease/Ablative Therapies - Surgery
- Type: Posters
- Track: Early Stage/Localized Disease/Ablative Therapies
- Presentations: 10
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P06.04 - Clinical Outcomes and Pathological Characteristics of Resected ALK+ Lung Adenocarcinoma: A Single Center Retrospective Analysis
00:00 - 00:00 | Presenter: Zihua Zou
- Abstract
Loading...
-
+
P40 - Multimodality of Advanced Lung Cancer - Clinical Outcomes
- Type: Posters
- Track: Multimodality of Advanced Lung Cancer
- Presentations: 20
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P40.01 - Maintenance Anlotinib After Induction Therapy With Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer: A Phase 2 Study
00:00 - 00:00 | Presenter: Yongqian Shu
- Abstract
Loading...
-
+
P45 - Novel Therapeutics and Targeted Therapies - ALK/ROS1/MET
- Type: Posters
- Track: Novel Therapeutics and Targeted Therapies
- Presentations: 18
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P45.08 - Lorlatinib for Previously Treated ALK-Positive Advanced NSCLC: Primary Efficacy and Safety Data from a Phase 2 Study in China
00:00 - 00:00 | Presenter: Shun Lu
- Abstract
Loading...
-
+
P51 - Novel Therapeutics and Targeted Therapies - EGFR Resistance
- Type: Posters
- Track: Novel Therapeutics and Targeted Therapies
- Presentations: 7
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P51.03 - Oritinib (SH-1028), a Third-generation EGFR-TKI in Advanced NSCLC Patients with Positive EGFR T790M: Results of a Single-arm Phase Ib Trial
00:00 - 00:00 | Presenter: Caicun Zhou
- Abstract
Loading...
-
+
P64 - Small Cell Lung Cancer/ NET - Clinical Trial in Progress
- Type: Posters
- Track: Small Cell Lung Cancer/ NET
- Presentations: 4
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P64.02 - EMERGE 402 Phase 4 Observational Study: Safety and Outcomes in Patients With SCLC Receiving Treatment With Lurbinectedin
00:00 - 00:00 | Presenter: Raj Hanvesakul
- Abstract
Loading...
-
+
OA06 - Prognosis and Staging
- Type: Oral
- Track: Staging/Pulmonary Medicine
- Presentations: 6
- Moderators:Ann Leung
- Coordinates: 9/09/2021, 08:15 - 09:15, Program Auditorium
-
+
OA06.01 - Validation of the 8th Ed TNM: Invasive Size for Pathologic T Descriptor in Stage I-IIA Resected Nonmucinous Adenocarcinomas
08:15 - 08:25 | Presenter: Yan Li
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
WS06 - Joint IASLC - CAALC - CSCO Workshop: Looking Toward the Future: Recognizing and Curing Lung Cancer
- Type: Workshop
- Track: N.A.
- Presentations: 9
- Moderators:Caicun Zhou
- Coordinates: 9/11/2021, 22:15 - 23:45, Program Auditorium
-
+
WS06.07 - Lorlatinib for Previously Treated ALK-Positive Advanced NSCLC: Primary Efficacy and Safety Data from a Phase 2 Study in China
23:13 - 23:23 | Presenter: Shun Lu
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MA13 - Building on the Past: What Will Be the Next Immunotherapy Combination?
- Type: Mini Oral
- Track: Immunotherapy (Phase II/III Trials)
- Presentations: 9
- Coordinates: 9/13/2021, 17:30 - 18:30, Program Auditorium
-
+
MA13.01 - Camrelizumab Plus Apatinib in Treatment-Naive Patients With Advanced Non-Squamous NSCLC: A Multicenter, Open-Label, Single-Arm, Phase 2 Trial
17:30 - 17:35 | Presenter: Shengxiang (Harry) Ren
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.